BioWorld - Sunday, June 7, 2026

BioWorld Science

Feb. 3, 2006

View Archived Issues

SuperGen to acquire Montigen Pharmaceuticals

Read More

Pharmos completes phase I study for cannabinor

Read More

CytRx to transfer RNAi therapeutics to new subsidiary

Read More

Rigel receives milestone payment from Merck ubiquitin ligase collaboration

Read More

Curcumin plus phenethyl isothiocyanate active against prostate cancer in vivo

Read More

H5N1 Avian influenza virus vaccine effective in mice and chickens

Read More

Albany Molecular Research to acquire ComGenex

Read More

IGFR inhibition shows promise for malignant mesothelioma

Read More

New D3R antagonist prevents negative symptoms of schizophrenia

Read More

New agents for immunological disorders imparted in recent Taisho patent

Read More

Recent patents describe new therapeutic agents for anxiety, depression etc.

Read More

Novel agents imparted for the treatment of inflammatory disorders

Read More

Shionogi describes new antiobesity agents in patent literature

Read More

CombinatoRx and Fovea to develop novel ophthalmic therapeutics

Read More

New phase I/II study for ZIO-101 in advanced myeloma

Read More

Thiovir active against influenza A virus in preclinical studies

Read More

Ardana holds pre-IND meeting with FDA for testosterone cream

Read More

Pharmexa files first application for phase III PrimoVax trial

Read More

Nastech and P&G collaborate on nasal PTH1-34

Read More

TP-508 promotes cartilage repair via activation of ERK1/2 MAPK

Read More

New respiratory agents highlighted in patent literature

Read More

Symphogen and Biovitrum to codevelop and commercialize SYM-001

Read More

Zalypsis to enter clinical testing in U.S.

Read More

LY-2275796 enters clinical trials in cancer patients

Read More

CONRAD and Cellegy sign agreement for microbicide R&D

Read More

Clarinex-D 12 Hour approved for seasonal allergic rhinitis

Read More

EMEA accepts for review Genasense MAA in melanoma

Read More